Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir and Daclatasvir Combo in COVID-19 Patients
NCT04773756Phase 4Completed
- Sponsor
- Alexandria University
- Start
- Nov 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sofosbuvir in coronavirus disease 2019 (COVID-19), sponsored by Alexandria University. Started Nov 2020; status: completed.
02
Drugs
sofosbuvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04773756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04773756.